Bridging the gap in patent assessment: The Index of Internal Effort framework for pharma innovations

Context: The process of assessing patents is complex, and there is a gap in the literature on patent assessment at the time of filing. Aims: To assess patent complexity and the human effort involved in research, we test the effectiveness of the Index of Internal Effort (IIE) framework using pharmace...

Full description

Saved in:
Bibliographic Details
Main Authors: Alisson A. de Oliveira (Author), Celso B. dos Santos (Author), Luiz A. Pilatti (Author)
Format: Book
Published: GarVal Editorial Ltda., 2024-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0de7d788e376401a8e09a97760f5b701
042 |a dc 
100 1 0 |a Alisson A. de Oliveira  |e author 
700 1 0 |a Celso B. dos Santos  |e author 
700 1 0 |a Luiz A. Pilatti  |e author 
245 0 0 |a Bridging the gap in patent assessment: The Index of Internal Effort framework for pharma innovations 
260 |b GarVal Editorial Ltda.,   |c 2024-09-01T00:00:00Z. 
500 |a 10.56499/jppres23.1859_12.5.852 
500 |a 0719-4250 
520 |a Context: The process of assessing patents is complex, and there is a gap in the literature on patent assessment at the time of filing. Aims: To assess patent complexity and the human effort involved in research, we test the effectiveness of the Index of Internal Effort (IIE) framework using pharmaceutical patents developed within the Brazilian public sector as a proof of concept. Methods: Internal data were collected from innovation projects that included the filing of patents as a project outcome. The Spearman correlation test was applied to determine which internal patent variables could be used as metrics in IIE. Then, IIE was used to measure the complexity of the patents and the individual effort of inventors. Results were then compared with other metrics identified in the literature. Results: The IIE showed a positive and significant correlation with resources invested at the design stage, as well as commercial and social outcomes of the patents. Conclusions: The results indicate that the generic IIE framework is a new form of metrification that can be applied to pharmaceutical patents that have not been previously discussed in the literature. 
546 |a EN 
546 |a ES 
690 |a data science 
690 |a fiocruz 
690 |a intellectual effort 
690 |a patent 
690 |a pharmacology 
690 |a public service 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacy & Pharmacognosy Research, Vol 12, Iss 5, Pp 852-869 (2024) 
787 0 |n https://jppres.com/jppres/pdf/vol12/jppres23.1859_12.5.852.pdf 
787 0 |n https://doaj.org/toc/0719-4250 
856 4 1 |u https://doaj.org/article/0de7d788e376401a8e09a97760f5b701  |z Connect to this object online.